Evidence map›Paper›PMID 37353484›Full record

ArticleNature communications2023

TRPV4-Rho GTPase complex structures reveal mechanisms of gating and disease.

Do Hoon Kwon, Feng Zhang, Brett A McCray, Shasha Feng, Meha Kumar, Jeremy M Sullivan, Wonpil Im, Charlotte J Sumner, Seok-Yong Lee

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Structural insights into TRPV2 modulation by probenecid.Nature structural & molecular biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Do Hoon Kwon *Department of Biochemistry, Duke University School of Medicine, Durham, NC, 27710, USA.ORCID 0000-0002-3214-3394
Feng Zhang *Department of Biochemistry, Duke University School of Medicine, Durham, NC, 27710, USA.
Brett A McCrayDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.ORCID 0000-0001-6581-9728
Shasha FengDepartments of Biological Sciences, Chemistry, and Bioengineering, Lehigh University, Bethlehem, PA, 18015, USA.ORCID 0000-0003-3394-6911
Meha KumarDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.ORCID 0000-0002-9549-0940
Jeremy M SullivanDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Wonpil ImDepartments of Biological Sciences, Chemistry, and Bioengineering, Lehigh University, Bethlehem, PA, 18015, USA.ORCID 0000-0001-5642-6041
Charlotte J SumnerDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.ORCID 0000-0001-5088-6012
Seok-Yong LeeDepartment of Biochemistry, Duke University School of Medicine, Durham, NC, 27710, USA. seok-yong.lee@duke.edu.ORCID 0000-0002-0662-9921
Johns Hopkins University · USDuke University · USLehigh University · US

Funding

Pacific Northwest Center for Cryo-EM - Screening supplementU24GM129547 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI EVANS, JAMES E, GOUAUX, JAMES E · 2018 to 2023
$54.8M
Translating Pathomechanisms into Treatment for Spinal Muscular AtrophiesR35NS122306 · NINDS · JOHNS HOPKINS UNIVERSITY · PI Charlotte Jane Sumner · 2021 to 2026
$6.3M
Structure, function, and pharmacology of neuronal membrane transport proteinsR35NS097241 · NINDS · DUKE UNIVERSITY · PI LEE, SEOK-YONG · 2016 to 2023
$6.1M
CHARMM-GUI Development for Biomolecular Modeling and Simulation CommunityR01GM138472 · NIGMS · LEHIGH UNIVERSITY · PI IM, WONPIL · 2020 to 2023
$1.5M
Pathogenesis of TRPV4-related peripheral neuropathyK08NS102509 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MCCRAY, BRETT ANDREW · 2018 to 2022
$997k
NIGMS NIH HHS R01 GM138472NIGMS NIH HHS U24 GM129547NINDS NIH HHS K08 NS102509NINDS NIH HHS R35 NS097241NINDS NIH HHS R35 NS122306
6 · The paper itself

Abstract

Crosstalk between ion channels and small GTPases is critical during homeostasis and disease, but little is known about the structural underpinnings of these interactions. TRPV4 is a polymodal, calcium-permeable cation channel that has emerged as a potential therapeutic target in multiple conditions. Gain-of-function mutations also cause hereditary neuromuscular disease. Here, we present cryo-EM structures of human TRPV4 in complex with RhoA in the ligand-free, antagonist-bound closed, and agonist-bound open states. These structures reveal the mechanism of ligand-dependent TRPV4 gating. Channel activation is associated with rigid-body rotation of the intracellular ankyrin repeat domain, but state-dependent interaction with membrane-anchored RhoA constrains this movement. Notably, many residues at the TRPV4-RhoA interface are mutated in disease and perturbing this interface by introducing mutations into either TRPV4 or RhoA increases TRPV4 channel activity. Together, these results suggest that RhoA serves as an auxiliary subunit for TRPV4, regulating TRPV4-mediated calcium homeostasis and disruption of TRPV4-RhoA interactions can lead to TRPV4-related neuromuscular disease. These insights will help facilitate TRPV4 therapeutics development.

Indexed as

rhoA GTP-Binding ProteinTRPV Cation ChannelsAnkyrin RepeatCalciumHumansMutationCalciumrhoA GTP-Binding ProteinRHOA protein, humanTRPV4 protein, humanTRPV Cation Channels

Identifiers

PMID37353484
PMCPMC10290081
OpenAlexW4381801298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.